Alfons H H Bongaerts Selected Research

Alfons H H Bongaerts Research Topics

4	Neoplasms (Cancer) 01/2018 - 07/2014
3	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2014
1	Hemorrhage 01/2016
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2016
1	Inflammation (Inflammations) 01/2016
1	Fecal Incontinence 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Pain (Aches) 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2016
1	Testicular Neoplasms (Testicular Cancer) 01/2016
1	Disease Progression 01/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2015
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2014

4	89Zr-bevacizumabIBA 01/2016 - 07/2014
3	Estrogen ReceptorsIBA 01/2018 - 08/2014
2	Pharmaceutical PreparationsIBA 12/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 07/2014
2	Bevacizumab (Avastin)FDA Link 01/2015 - 07/2014
1	16-fluoroestradiolIBA 01/2018
1	AndrogensIBA 12/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2017
1	human ERBB2 proteinIBA 12/2017
1	Growth Differentiation Factor 15IBA 01/2016
1	V 70 (V70)IBA 01/2016
1	AnticoagulantsIBA 01/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Sunitinib (Sutent)FDA Link 01/2015
1	InterferonsIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 08/2014
1	zirconium-89-trastuzumabIBA 08/2014
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	Everolimus FDA Link 07/2014